3 hasil untuk "Tyler Halladay"
Menampilkan 1–3 · 0,26 detik · RSS
-
Artikel Jurnal
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to…
-
Artikel Jurnal
Engineering optimal CAR constructs for allogeneic mesothelin-directed CAR-NKT cells in solid tumor immunotherapy
Abstract: Chimeric antigen receptor (CAR)–engineered cell therapies have revolutionized cancer immunotherapy and are expanding into other diseases, including autoimmune disorders. Optimizing CAR design, particularly the choice of costimulatory domains and the incorporation of immune-enhancing…
-
Artikel Jurnal
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells
Summary: Renal cell carcinoma (RCC) represents about 90% of kidney cancers, with 30%–40% of patients developing metastatic disease despite current treatments. Conventional chimeric antigen receptor (CAR)-T therapy targeting CD70 shows promise but faces challenges due to its autologous, personalized…